Beneficial Use of the Combination of Gemcitabine and Dacarbazine in Advanced Soft Tissue Sarcomas: Real-World Data

Beneficial Use of the Combination of Gemcitabine and Dacarbazine in Advanced Soft Tissue Sarcomas: Real-World Data

Background: The combination of gemcitabine and dacarbazine has exhibited efficacy in terms of progression-free survival (PFS) and overall survival (OS) for aSTSs, albeit without robust confirmation from larger clinical trials. Methods: We conducted a retrospective study in a single institution invol...

Full description

Bibliographic Details
Main Authors: Ibon Gurruchaga Sotés, M. Carmen Gómez-Mateo, María Eugenia Ortega Izquierdo, Javier Martínez-Trufero
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Cancers
Subjects:
advanced soft tissue sarcoma
gemcitabine
dacarbazine
prognostic index
biomarker
Online Access:https://www.mdpi.com/2072-6694/16/2/267

Internet

https://www.mdpi.com/2072-6694/16/2/267

Similar Items